[Trabecular micro-invasive glaucoma surgery : Procedures and clinical results]

Area of Science:

• Ophthalmology
• Glaucoma Management
• Surgical Innovation

Background:

• Glaucoma treatment typically progresses from medication to laser and filtration surgery.
• Limitations of current therapies include local side effects, poor patient adherence, and surgical complications.

Purpose of the Study:

• To review the emerging field of Micro-Invasive Glaucoma Surgery (MIGS).
• To detail specific trabecular implants: iStent, iStent inject, and Hydrus Microstent.
• To evaluate the efficacy and safety of these MIGS devices based on existing data.

Main Methods:

• Literature review of current data on trabecular implants for glaucoma.
• Detailed presentation of iStent, iStent inject, and Hydrus Microstent.
• Analysis of published studies on the effectiveness and safety of these devices.

Main Results:

• Microstents represent a novel surgical approach in glaucoma management.
• These implants may reduce the reliance on glaucoma medications.
• MIGS procedures can potentially postpone the need for more invasive filtration surgery.

Conclusions:

• Micro-Invasive Glaucoma Surgery (MIGS) is a developing area in glaucoma treatment.
• Trabecular implants offer a potential to decrease medication burden and delay filtration surgery.
• Further data is needed to fully establish the long-term effectiveness and safety profile of MIGS devices.